When Josie Nixon visited her health insurer’s website seeking a coronavirus vaccine, she felt invisible: On a registration form that collected personal and demographic information, the 29-year-old Denver resident had to select “other” for her gender.
There was no option for “transgender woman.” Days before, Ms. Nixon had felt a sense of hope when President Biden announced his nomination of Dr.
Rachel Levine, a transgender woman, to one of the nation’s top health posts and signed an executive order aimed at ameliorating Covid-19 health inequities in the country’s most vulnerable communities.
But her experience was a stark reminder, she said, that the nation’s estimated 11.3 million L.G.B.T.Q. adults still have a long way to go toward.